Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 2
2020 2
2021 4
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Targeted Delivery of Pennyroyal via Methotrexate Functionalized PEGylated Nanostructured Lipid Carriers into Breast Cancer Cells; A Multiple Pathways Apoptosis Activator.
Mahoutforoush A, Asadollahi L, Hamishehkar H, Abbaspour-Ravasjani S, Solouk A, Haghbin Nazarpak M. Mahoutforoush A, et al. Among authors: abbaspour ravasjani s. Adv Pharm Bull. 2023 Nov;13(4):747-760. doi: 10.34172/apb.2023.077. Epub 2023 Apr 29. Adv Pharm Bull. 2023. PMID: 38022805 Free PMC article.
Sirolimus- and cyclosporine-loaded nanostructured lipid carriers: Development, characterization, and in vitro evaluation in T-cell profiles of patients with a history of recurrent pregnancy loss.
Parhizkar F, Yousefi M, Soltani-Zangbar MS, Parhizkar Z, Aghebati-Maleki L, Abbaspour-Ravasjani S, Motavalli R, Alizadegan A, Mojahedi M, Baharaghdam S, Kamrani A, Danaii S, Talebi M, Jadidi-Niaragh F, Hamishehkar H, Kafil HS, Mahmoodpoor A, Heris JA. Parhizkar F, et al. Among authors: abbaspour ravasjani s. Reprod Med Biol. 2023 Mar 20;22(1):e12509. doi: 10.1002/rmb2.12509. eCollection 2023 Jan-Dec. Reprod Med Biol. 2023. PMID: 36949822 Free PMC article.
CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice.
Sepasi T, Ghadiri T, Ebrahimi-Kalan A, Bani F, Talebi M, Rahbarghazi R, Khodakarimi S, Beyrampour-Basmenj H, Seidi K, Abbaspour-Ravasjani S, Sadeghi MR, Zarebkohan A, Gao H. Sepasi T, et al. Among authors: abbaspour ravasjani s. Int J Pharm. 2023 Apr 5;636:122815. doi: 10.1016/j.ijpharm.2023.122815. Epub 2023 Mar 11. Int J Pharm. 2023. PMID: 36907279
Corrigendum to "Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis" [Int. J. Pharm. 618 (2022) 121656].
Paiva-Santos AC, Gama M, Peixoto D, Sousa-Oliveira I, Ferreira-Faria I, Zeinali M, Abbaspour-Ravasjani S, Mascarenhas-Melo F, Hamishehkar H, Veiga F. Paiva-Santos AC, et al. Among authors: abbaspour ravasjani s. Int J Pharm. 2022 Nov 5;627:122146. doi: 10.1016/j.ijpharm.2022.122146. Epub 2022 Sep 24. Int J Pharm. 2022. PMID: 36167592 No abstract available.
Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation.
Asadollahi L, Mahoutforoush A, Dorreyatim SS, Soltanfam T, Paiva-Santos AC, Peixoto D, Veiga F, Hamishehkar H, Zeinali M, Abbaspour-Ravasjani S. Asadollahi L, et al. Among authors: abbaspour ravasjani s. Int J Pharm. 2022 Aug 25;624:122027. doi: 10.1016/j.ijpharm.2022.122027. Epub 2022 Jul 16. Int J Pharm. 2022. PMID: 35850183
CTLA-4: As an Immunosuppressive Immune Checkpoint in Breast Cancer.
Ghahremani Dehbokri S, Alizadeh N, Isazadeh A, Baghbanzadeh A, Abbaspour-Ravasjani S, Hajiasgharzadeh K, Baradaran B. Ghahremani Dehbokri S, et al. Among authors: abbaspour ravasjani s. Curr Mol Med. 2023;23(6):521-526. doi: 10.2174/1566524022666220610094716. Curr Mol Med. 2023. PMID: 35692146 Review.
Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis.
Cláudia Paiva-Santos A, Gama M, Peixoto D, Sousa-Oliveira I, Ferreira-Faria I, Zeinali M, Abbaspour-Ravasjani S, Mascarenhas-Melo F, Hamishehkar H, Veiga F. Cláudia Paiva-Santos A, et al. Among authors: abbaspour ravasjani s. Int J Pharm. 2022 Apr 25;618:121656. doi: 10.1016/j.ijpharm.2022.121656. Epub 2022 Mar 9. Int J Pharm. 2022. PMID: 35278601 Free article. Review.
Silencing of HMGA2 by siRNA Loaded Methotrexate Functionalized Polyamidoamine Dendrimer for Human Breast Cancer Cell Therapy.
Abedi Gaballu F, Cho WC, Dehghan G, Zarebkohan A, Baradaran B, Mansoori B, Abbaspour-Ravasjani S, Mohammadi A, Sheibani N, Aghanejad A, Ezzati Nazhad Dolatabadi J. Abedi Gaballu F, et al. Among authors: abbaspour ravasjani s. Genes (Basel). 2021 Jul 20;12(7):1102. doi: 10.3390/genes12071102. Genes (Basel). 2021. PMID: 34356120 Free PMC article.
16 results